Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms, Germ Cell and Embryonal × fludarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 66 Leukemia 63 Leukemia, Lymphocytic, Chronic, B-Cell 59 Myelodysplastic Syndromes 49 Lymphoma 44 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Lymphoma, Non-Hodgkin 41 Multiple Myeloma 37 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 35 Hodgkin Disease 33 Melanoma 25 Hematologic Neoplasms 23 Myeloproliferative Disorders 16 Recurrence 15 Neoplasms 15 Neoplasm Metastasis 15 Lymphoma, Follicular 14 Primary Myelofibrosis 13 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 12 Lymphoma, Large B-Cell, Diffuse 12 Skin Neoplasms 11 Graft vs Host Disease 10 Burkitt Lymphoma 10 Lymphoma, B-Cell, Marginal Zone 9 Anemia, Refractory, with Excess of Blasts 9 Lymphoma, B-Cell 8 Breast Neoplasms 8 Ovarian Neoplasms 7 Leukemia, Prolymphocytic 7

Interventions

pralsetinib 2 pembrolizumab 2 Brentuximab Vedotin 2 Bevacizumab 2 ribociclib 1 fosaprepitant 1 Sunitinib 1 Sirolimus 1 Radiotherapy, Image-Guided 1 Plicamycin 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Genistein 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dexamethasone 1 Cisplatin 1 Carboplatin 1 Aprepitant 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡